Literature DB >> 18209086

The myeloid differentiation factor 88 (MyD88) is required for CD4+ T cell effector function in a murine model of inflammatory bowel disease.

Masayuki Fukata1, Keith Breglio, Anli Chen, Arunan S Vamadevan, Tyralee Goo, David Hsu, Daisy Conduah, Ruliang Xu, Maria T Abreu.   

Abstract

Abnormal T cell responses to commensal bacteria are involved in the pathogenesis of inflammatory bowel disease. MyD88 is an essential signal transducer for TLRs in response to the microflora. We hypothesized that TLR signaling via MyD88 was important for effector T cell responses in the intestine. TLR expression on murine T cells was examined by flow cytometry. CD4(+)CD45Rb(high) T cells and/or CD4(+)CD45Rb(low)CD25(+) regulatory T cells were isolated and adoptively transferred to RAG1(-/-) mice. Colitis was assessed by changes in body weight and histology score. Cytokine production was assessed by ELISA. In vitro proliferation of T cells was assessed by [(3)H]thymidine assay. In vivo proliferation of T cells was assessed by BrdU and CFSE labeling. CD4(+)CD45Rb(high) T cells expressed TLR2, TLR4, TLR9, and TLR3, and TLR ligands could act as costimulatory molecules. MyD88(-/-) CD4(+) T cells showed decreased proliferation compared with WT CD4(+) T cells both in vivo and in vitro. CD4(+)CD45Rb(high) T cells from MyD88(-/-) mice did not induce wasting disease when transferred into RAG1(-/-) recipients. Lamina propria CD4(+) T cell expression of IL-2 and IL-17 and colonic expression of IL-6 and IL-23 were significantly lower in mice receiving MyD88(-/-) cells than mice receiving WT cells. In vitro, MyD88(-/-) T cells were blunted in their ability to secrete IL-17 but not IFN-gamma. Absence of MyD88 in CD4(+)CD45Rb(high) cells results in defective T cell function, especially Th17 differentiation. These results suggest a role for TLR signaling by T cells in the development of inflammatory bowel disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18209086      PMCID: PMC2828823          DOI: 10.4049/jimmunol.180.3.1886

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  70 in total

Review 1.  Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors.

Authors:  T Hirano; K Ishihara; M Hibi
Journal:  Oncogene       Date:  2000-05-15       Impact factor: 9.867

Review 2.  Cytokines induce the development of functionally heterogeneous T helper cell subsets.

Authors:  A O'Garra
Journal:  Immunity       Date:  1998-03       Impact factor: 31.745

Review 3.  CD4+ T-cells in the regulation of inflammatory responses in the intestine.

Authors:  F Powrie; S Mauze; R L Coffman
Journal:  Res Immunol       Date:  1997 Oct-Dec

4.  Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo.

Authors:  R Atreya; J Mudter; S Finotto; J Müllberg; T Jostock; S Wirtz; M Schütz; B Bartsch; M Holtmann; C Becker; D Strand; J Czaja; J F Schlaak; H A Lehr; F Autschbach; G Schürmann; N Nishimoto; K Yoshizaki; H Ito; T Kishimoto; P R Galle; S Rose-John; M F Neurath
Journal:  Nat Med       Date:  2000-05       Impact factor: 53.440

5.  In vitro activated CD4+ T cells from interferon-gamma (IFN-gamma)-deficient mice induce intestinal inflammation in immunodeficient hosts.

Authors:  S Bregenholt; J Brimnes; M H Nissen; M H Claesson
Journal:  Clin Exp Immunol       Date:  1999-11       Impact factor: 4.330

6.  CD45RBhigh CD4+ T cells from IFN-gamma knockout mice do not induce wasting disease.

Authors:  H Ito; C G Fathman
Journal:  J Autoimmun       Date:  1997-10       Impact factor: 7.094

7.  Colonic bacteria express an ulcerative colitis pANCA-related protein epitope.

Authors:  O Cohavy; D Bruckner; L K Gordon; R Misra; B Wei; M E Eggena; S R Targan; J Braun
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

8.  Analysis of intestinal lymphocytes in mouse colitis mediated by transfer of CD4+, CD45RBhigh T cells to SCID recipients.

Authors:  R Aranda; B C Sydora; P L McAllister; S W Binder; H Y Yang; S R Targan; M Kronenberg
Journal:  J Immunol       Date:  1997-04-01       Impact factor: 5.422

9.  Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)

Authors:  R Duchmann; I Kaiser; E Hermann; W Mayet; K Ewe; K H Meyer zum Büschenfelde
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

10.  T cell-mediated pathology in two models of experimental colitis depends predominantly on the interleukin 12/Signal transducer and activator of transcription (Stat)-4 pathway, but is not conditional on interferon gamma expression by T cells.

Authors:  S J Simpson; S Shah; M Comiskey; Y P de Jong; B Wang; E Mizoguchi; A K Bhan; C Terhorst
Journal:  J Exp Med       Date:  1998-04-20       Impact factor: 14.307

View more
  61 in total

1.  The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota.

Authors:  June L Round; S Melanie Lee; Jennifer Li; Gloria Tran; Bana Jabri; Talal A Chatila; Sarkis K Mazmanian
Journal:  Science       Date:  2011-04-21       Impact factor: 47.728

2.  Pathogenic and protective roles of MyD88 in leukocytes and epithelial cells in mouse models of inflammatory bowel disease.

Authors:  Mark J Asquith; Olivier Boulard; Fiona Powrie; Kevin J Maloy
Journal:  Gastroenterology       Date:  2010-04-28       Impact factor: 22.682

3.  A "Toll" for Th17 cell expansion.

Authors:  Eduardo Davila; Jay Kolls
Journal:  J Leukoc Biol       Date:  2010-07       Impact factor: 4.962

4.  NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis.

Authors:  Simon A Hirota; Jeffrey Ng; Alan Lueng; Maitham Khajah; Ken Parhar; Yan Li; Victor Lam; Mireille S Potentier; Kelvin Ng; Misha Bawa; Donna-Marie McCafferty; Kevin P Rioux; Subrata Ghosh; Ramnik J Xavier; Sean P Colgan; Jurg Tschopp; Daniel Muruve; Justin A MacDonald; Paul L Beck
Journal:  Inflamm Bowel Dis       Date:  2010-09-24       Impact factor: 5.325

5.  Commensal microbiota drive proliferation of conventional and Foxp3(+) regulatory CD4(+) T cells in mesenteric lymph nodes and Peyer's patches.

Authors:  Sascha Cording; Diana Fleissner; Markus M Heimesaat; Stefan Bereswill; Christoph Loddenkemper; Satoshi Uematsu; Shizuo Akira; Alf Hamann; Jochen Huehn
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2013-03-13

6.  Signaling through the adaptor molecule MyD88 in CD4+ T cells is required to overcome suppression by regulatory T cells.

Authors:  Dominik Schenten; Simone A Nish; Shuang Yu; Xiting Yan; Heung Kyu Lee; Igor Brodsky; Lesley Pasman; Brian Yordy; F Thomas Wunderlich; Jens C Brüning; Hongyu Zhao; Ruslan Medzhitov
Journal:  Immunity       Date:  2014-01-16       Impact factor: 31.745

7.  Age-related T-cell cytokine profile parallels corneal disease severity in Sjogren's syndrome-like keratoconjunctivitis sicca in CD25KO mice.

Authors:  Cintia S De Paiva; Cindy S Hwang; John D Pitcher; Solherny B Pangelinan; Ehsan Rahimy; Wei Chen; Kyung-Chul Yoon; William J Farley; Jerry Y Niederkorn; Michael E Stern; De-Quan Li; Stephen C Pflugfelder
Journal:  Rheumatology (Oxford)       Date:  2009-12-09       Impact factor: 7.580

Review 8.  Coordination of tolerogenic immune responses by the commensal microbiota.

Authors:  June L Round; Ryan M O'Connell; Sarkis K Mazmanian
Journal:  J Autoimmun       Date:  2009-12-06       Impact factor: 7.094

9.  Periductal interleukin-17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosis.

Authors:  K Harada; S Shimoda; Y Sato; K Isse; H Ikeda; Y Nakanuma
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

10.  TLR4 signaling in effector CD4+ T cells regulates TCR activation and experimental colitis in mice.

Authors:  José M González-Navajas; Sean Fine; Jason Law; Sandip K Datta; Kim P Nguyen; Mandy Yu; Maripat Corr; Kyoko Katakura; Lars Eckman; Jongdae Lee; Eyal Raz
Journal:  J Clin Invest       Date:  2010-01-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.